Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA ...
The world's first vaccine for ovarian cancer, which is being developed in the UK, could eradicate the lethal disease, ...
Reed, now aged 33, has now launched a $US200m fund called Yosemite – spun out of Emerson Collective, the philanthropic ...
A STUDY has found the main ingredient in ‘lethal’ painkiller Nolotil could be twice as dangerous for women than men. Just ...
Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing skin pigment, and is known ...
Breakthrough research sheds light on the genetic mutation behind aggressive prostate ... render prostate tumors vulnerable to synthetic lethal paralog enzymes. The researchers tested the effects ...
World Sight Day aims to raise awareness of vision impairment and blindness, and promote eye care. Read more at ...
Lupus is a lifelong, often painful and occasionally lethal autoimmune disease ... to guarantee that each patient is given the drug that targets the specific genetic mutation responsible for their ...
Chris Jankulovski is a close friend of mine from the Entrepreneur’s Organization. The story of this Ozzie is one of extreme tragedy and extreme triumph. So remarkable is his spirit that he changed my ...
Key mechanism of resistance to BRAF-targeted melanoma therapy discovered. Potential for developing new cancer therapies with high efficacy by regulating polyamine biosynthesis to suppress resistance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback